TRIO and cyclic hematopoiesis: Together, these findings expand the phenotypic spectrum associated with pathogenic <i>TRIO</i> variation to include CV/CH and support <i>TRIO</i> as a clinically relevant gene in the genetic evaluation of syndromic CV/CH patients.